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Study participants were members of an existing, national online-probability panel of 131 55,000 non-institutionalized U.S. adults recruited through address-based sampling. 9 Panel 132 members without a computer and internet access received these resources; those who already had R e v i e w C o p y 6 133 a computer and internet access received points for completing the survey, which could be 134 redeemed for cash, products, or sweepstakes entries. Eligible respondents were parents of at least 135 one child age 9-17 who either had not initiated the HPV vaccine series or had received only the 136 first dose. From November 2017 to January 2018, the survey company contacted a random 137 sample of 2,857 parents via email. Of these parents, 1,834 parents visited the survey website and 138 had an age-eligible child (age 9-17) with 0 or 1 dose of HPV vaccine. Of these respondents, 139 1,313 parents (72%) met eligibility criteria, provided informed consent, and completed some 140 portion of the survey. After we excluded 50 panelists who did not complete at least two-thirds of 141 the survey, our surveyed sample contained 1,263 parents. The response rate was 61%, based on 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Table 3) . We also calculated the percentage of parents who were 196 more confident in HPV vaccine after message exposure (Figure 1) . We defined the proportion of 197 parents who were more confident as those who responded "moderately" or a "lot" to the 198 confidence items. To identify correlates of parents' confidence in HPV vaccine or motivation to 199 get HPV vaccine for their children, we constructed multilevel linear models to account for within 200 subject repeated-measures of study outcomes (Table 4) . For each outcome, we first evaluated 
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With respect to message characteristics, parents exposed to messages that addressed lack 241 of knowledge (b=.13, p=.01) were more confident in HPV vaccine compared to parents who 242 were exposed to messages addressing concerns in adjusted analyses (Table 4 ). Parents exposed 243 to messages that had a higher reading grade level (b=.02, p=.01) or messages that were longer 244 (b=.03, p<.001) were more confident in HPV vaccine. Additionally, parents exposed to messages 245 about cancer prevention (b=.11, p<.001) were more confident in HPV vaccine. In contrast, 246 parents exposed to messages that expressed urgency (b=-.06, p=.005) had lower confidence in 247 HPV vaccine. Finally, parents exposed to messages that contained first and second-person 293 the use of personal pronouns may undercut the impact of explanations. We found that using self-294 referential language such as "my clinic", "we can prevent", and "your child" in answers to 319 confidence in and motivation to get HPV vaccine alone may not increase vaccine uptake; they 320 could however increase uptake in combination with clear, strong provider recommendations to 321 get the vaccine, as other studies have shown. 4, 5, 26 The validity of our findings must also be 322 interpreted in light of the fact that parents were exposed to a separate experiment of pre-recorded 323 videos of vaccine recommendation strategies prior to viewing the messages they were randomly 324 assigned to in our current study. While randomization in both experiments showed no observable 325 selection bias in our seven topic conditions, parents were likely primed to pay closer attention to 326 our messages which could have influenced processing of these messages. Finally, because we 327 assigned parents to review messages about topics they had expressed some interest in, the 328 effectiveness of our messages in other contexts remains to be established. Table 5 . For the most part, they are the most effective messages in eliciting confidence 332 and motivation for each HPV vaccine topic. We adjusted the messages in places to align with the 333 communication principles described above. Providers may take these messages as a starting 334 point and elaborate as needed. In our study, messages elicited higher confidence when they were 335 longer and required a higher reading grade level. We aimed for shorter messages that providers 336 could remember. However, parents seeking information may prefer longer answers (i.e., 337 translates to a longer discussion). In a study such as ours, the trade-off between a vaccine 338 discussion and receiving other care may not have been as salient as it would be in a clinical visit.
339 Our study sample also skewed to parents with higher educational attainment, which could also 340 explain the preference for more complex messages. As a means of conveying complex :09 36% 25% 71% 1. HPV infection can cause cancer in both men and women. The HPV vaccine will protect your child from many of these cancers. 5 :09   2. HPV is so common that almost everyone will get it at some point. Most people will never know they are infected. We can prevent it by starting HPV vaccination today. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 C o p y 23 Confidence and motivation had four-point response scales: 1 = "not at all" to 4 = "a lot." Lack of knowledge topics: Diseases prevented by HPV vaccine, the age to start HPV vaccine series, vaccination for boys and girls, national recommendations for HPV vaccination. Concerns topics: Safety and side effects, vaccination for children not sexually active, school requirements for HPV vaccination. Parent attitude towards vaccines assessed using The Vaccine Confidence Scale that measures attitudes towards adolescent vaccines 23 Parent trait reactance assessed using a brief scale that measures resistance that arises when a person feels their autonomy is threatened 21 Intraclass correlation (ICC), confidence model = .79, motivation model = .82 *p<.05; **p<.001 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 C o p y 25 The age to start HPV vaccine series Kids respond more strongly to HPV vaccine when they are younger. This may give better protection against some cancers.
Vaccination for boys and girls HPV infections don't care if you're a boy or girl. The virus can cause cancer and many other diseases.
National recommendations for HPV vaccine Experts at the CDC agree that kids should get the HPV vaccine by age 11 or 12 to prevent several cancers. Concerns
Safety and side effects
This vaccine is one of the most studied medications on the market. The HPV vaccine is safe, just like the other vaccines given at this age. Vaccination for children not sexually active This really isn't about sex. The HPV vaccine is about preventing cancer.
School requirements for vaccination
School requirements don't always keep up with medical science. The HPV vaccine is an important vaccine that can prevent many cancers. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 C o p y Randomization. The survey first assessed how much parents would like to know from their child's health care provider about seven different HPV vaccination topics. Four topics were related to lack of knowledge or needing more information (diseases prevented by HPV vaccine; the age to start HPV vaccine series; vaccinations for boys and girls; national recommendations for HPV vaccine), and three topics were related to concerns (safety and side effects; vaccination for children not sexually active; and school requirements for vaccination). The three-point response scale was "none," "a little," and "a lot." The survey also assessed which topic parents 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1. For responses of "a little" or "a lot" to any of the seven questions, the survey software placed the parent in one of those topic conditions randomly without replacement.
2. For responses of "none" to all of the seven questions, the survey software randomly assigned the parent to one of the topic conditions without replacement.
Once randomized, parents watched four prerecorded video messages about that topic in a random order, all delivered by a female board-certified pediatrician (KT). Parents then answered questions about how it affected them. The sample size of each topic condition ranged from 163
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